Middle East and Africa Smoking Cessation Aids Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and End User

The electronic cigarettes segment by product is estimated to lead the market growth during the forecast period.

According to a new market research study of “Middle East and Africa Smoking Cessation Aids Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, End-user and Country.” The Middle East and Africa smoking cessation aids market is expected to reach US$ 3,118.37 million by 2028 from US$ 1,254.94 million in 2021; it is estimated to grow at a CAGR of 13.9% from 2021 to 2028. The report highlights trends prevailing in the Middle East and Africa smoking cessation aids market and the factors driving market along with those that act as hindrances. Key factors that are driving the growth of this market are rising addiction toward tobacco smoking and increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.

The government and nongovernment organizations worldwide are coming forward and launching campaigns to provide awareness and undertake measures to curb the diseases caused due to smoking and tobacco consumption. The measures are taken to reduce the economic and health burden caused due to cigarette smoking in countries worldwide. For instance, every year on May 31st, the WHO along with its global partners celebrate World No Tobacco Day (WNTD) to spread education and awareness regarding the harmful and deadly effects of tobacco and second-hand smoke exposure. Initiatives undertaken on this day mainly aim to discourage the consumption of tobacco in any form and educate people regarding the availability of aids that assist in smoking cessation. The launch of anti-smoking campaigns is organized on global, national, and regional levels worldwide. The governments of various countries have increased excise duties and taxes on tobacco-based cigarettes and cigars to reduce its affordability and thus consumption among common populace. In addition, numerous governments have legalized the use of e-cigarettes as a smoking cessation aid under licensed sales channels to prevent people from opting conventional cigarettes. Thus, the increasing efforts undertaken by governments as well as non-profit and nongovernment organizations to promote the use of smoking cessation aids and reduce the number of smoking populations boost the market growth. The substance and tobacco abuse treatment industry are getting competitive every consecutive year with the introduction of new and innovative therapies by the market players for smoking cessation aids. In addition, medical devices such as nicotine-free e-cigarettes and vapes are being launched by market players at local and regional levels. Thus, the consistent launch of new and innovative smoking cessation aids would become a prevalent trend in the smoking cessation aids market in the coming years.

The Middle East and Africa region is highly affected due to the outbreak of the COVID-19 pandemic. A major discussion is raging concerning the possible link between COVID-19 severity and tobacco use. The World Health Organization (WHO) published a scientific brief on May 26, 2020, concluding that “the existing evidence suggests that smoking is associated with higher severity of illness and death in hospitalized COVID-19 patients.” Hence for increasing risk for COVID-19, smoking is the major cause of underlying health conditions. However, there is currently insufficient information to confirm any link between tobacco or nicotine in the prevention or treatment of COVID-19. Hence, the impact of the COVID-19 pandemic on smoking cessation aids market is low in Middle East region.

The Middle East and Africa smoking cessation aids market, by product, is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. Based on End-user, the Middle East and Africa smoking cessation aids market is segmented into hospital pharmacies, online channel, retail pharmacies, and other End-users. Geographically, the Middle East and Africa smoking cessation aids market can be bifurcated into UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa.

Pfizer Inc. GlaxoSmithKline plc. Dr. Reddy's Laboratories, Johnson and Johnson Services, Inc. Cipla Inc. Perrigo Company plc, Bausch Health Companies Inc. and Glenmark are among the leading companies operating in the Middle East and Africa smoking cessation aids market

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa smoking cessation aids market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa smoking cessation aids market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.